"Hongyuan Company" is an international pharmaceutical enterprise integrating R & D, production and sales, and is one of the earliest companies undertaking the production of hormone bulk drugs and pharmaceutical intermediates in China. With more than 30 years of steroid hormone bulk drugs research, development and production, the company has established cooperative laboratory with the research institutions of a number of key universities, many drug R & D centers and product bases in China and branch offices overseas (USA). Our former bulk drug R & D and production base headquarter is located in Xianju in Zhejiang (the hometown of steroid hormone in China). Due to the needs of our rapid development, our R & D and production base headquarter has moved to Zhangshu in Jiangxi (80km from Nanchang, in one hour economic circle range in Nanchang) where is known as the "Chinese medicine capital" in July 2007 and we incorporated "Jiangxi Hongyuan Pharmaceutical Raw Materials Co., Ltd.".Jiangxi Hongyuan Pharmaceutical Raw Materials Co., Ltd. has an initial investment of 500 million yuan, covers an area of 115mu (76,705 square meters) and has completed nearly 20 steroid hormone production workshops and one steroid hormone research and development center. The second phase investment is 1.5 billion yuan and taking over 500mu (333,500 square meters) of land. We will build the largest steroid hormone production and R & D base in China.The company has strong technical force, about 300 employees including more than 50% of senior and medium professional technicians, 5 R & D personnel with doctor's degree, and more than 10 technical and management personnel with master's degree. Our steroid hormone and pharmaceutical intermediate production technology and product quality have reached international advanced level. Our company is one of a handful of domestic steroid hormone production enterprises that master the microbial conversion technology, fine strains breeding and other key technologies, the main domestic manufacturer and supplier of the key intermediates in steroid hormone industry, 16α,17-epoxy-11α-hydroxypregn-4-ene-3,20-dione, 16,17α-epoxy-11α-hydroxypregn-1,4-diene-3,21-dione and androstenedione (4AD), and one of the main manufacturer of steroid hormone medicines bulk drug (API pharmaceutical active ingredients) such as cortisone acetate, prednisone acetate, prednisolone, progesterone, medroxyprogesterone acetate, etc. Our products have advanced technology, excellent quality and competitive cost, and occupy a large market share in domestic and international steroid hormone market. The company has established more perfect sales and service network and dedicated overseas sales subsidiary in the United States.The company is in high-speed development period now. Our GMO reengineering, FDA certification COS registration and other related work are in an orderly way and we are about to obtain GMP and COS certificates. After finishing the second phase of construction, it is expected to achieve the output value of more than 2 billion yuan. The company's joint-stock reformation and listing work are in the preparation.